Top Markets
Coin of the day
InDex Pharmaceuticals Holding AB (publ) InDex Pharmaceuticals Holding AB (publ)

InDex Pharmaceuticals Holding AB (publ)

INDEX
Pozycja w akcjach #28996
InDex Pharmaceuticals Holding AB (publ) is a pharmaceutical firm dedicated to... InDex Pharmaceuticals Holding AB (publ) is a pharmaceutical firm dedicated to developing therapeutic solutions for patients affected by ulcerative colitis. The company's flagship drug candidate, Cobitolimod, is presently in Phase III clinical trials, targeting the treatment of moderate to severe ulcerative colitis. Furthermore, InDex is progressing a pipeline of other DNA-based immunomodulatory sequences, which are in the preclinical phase, designed to address various immunological conditions. This enterprise was established in 2000 and operates from its headquarters in Solna, Sweden.
Cena akcji
$0.04406501
Ostatnia synchronizacja: 2024-07-09
Kapitalizacja rynkowa
$23.47M
Zmiana (1 dzień)
-0.48%
Zmiana (1 rok)
0.00%
Kraj
SE
Handel InDex Pharmaceuticals Holding AB (publ) (INDEX)

Kategoria

Historia stopy dywidendy dla InDex Pharmaceuticals Holding AB (publ) (INDEX)
Stopa dywidendy (TTM) dla InDex Pharmaceuticals Holding AB (publ) (symbol akcji: INDEX) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla InDex Pharmaceuticals Holding AB (publ) (INDEX) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji